STAAR Surgical Company (STAA)

Cash ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents US$ in thousands 183,038 127,432 94,695 89,968 86,480 129,242 202,490 193,067 199,706 196,246 173,083 162,344 152,453 128,338 116,315 110,851 119,968 112,327 103,251 102,111
Short-term investments US$ in thousands 37,688 60,681 97,312 113,879 125,159 82,091
Total current liabilities US$ in thousands 65,036 56,775 54,194 47,063 51,716 45,320 46,514 41,182 48,802 46,796 41,801 36,129 41,236 33,859 31,589 29,902 34,478 29,972 28,711 28,231
Cash ratio 3.39 3.31 3.54 4.33 4.09 4.66 4.35 4.69 4.09 4.19 4.14 4.49 3.70 3.79 3.68 3.71 3.48 3.75 3.60 3.62

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($183,038K + $37,688K) ÷ $65,036K
= 3.39

The cash ratio of STAAR Surgical Company has exhibited stability and consistency over the past five years, ranging between 3.31 and 4.69. The ratio measures the company's ability to cover its short-term liabilities with its cash and cash equivalents.

STAAR Surgical Company has maintained a healthy cash ratio above 3.0, indicating a strong liquidity position and ability to meet its immediate obligations. The company's cash ratio trend suggests that it has effectively managed its cash resources to ensure financial stability.

Overall, the consistent levels of the cash ratio reflect STAAR Surgical Company's prudence in managing its cash position, which is essential for supporting ongoing operations, capital investments, and potential growth opportunities.


Peer comparison

Dec 31, 2023

Company name
Symbol
Cash ratio
STAAR Surgical Company
STAA
3.39
National Vision Holdings Inc
EYE
0.38
The Cooper Companies Inc.
COO
0.14